Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Conus

Showing results (221-230 of 289) with videos related to

Pageof 29
Sort By:
Basic & Clinical Pharmacology & Toxicology|February 12, 2022
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohortGeorgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Molecular Psychiatry|May 12, 2023
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysisJennifer Sjaarda, Aurélie Delacrétaz, Céline Dubath, et al.
Frontiers in Psychiatry|October 2, 2019
Promotion of Wellbeing for Children of Parents With Mental Illness: A Model Protocol for Research and InterventionCharlotte Reedtz, Karin van Doesum, Giulia Signorini, et al.
Plos One|December 3, 2020
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medicationLuis Alameda, Axel Levier, Mehdi Gholam-Rezaee, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophreniaMichael Berk, Ahmed Munib, Olivia Dean, et al.
Schizophrenia Bulletin|July 15, 2025
Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to AripiprazoleCécile Gras, Marianna Piras, Setareh Ranjbar, et al.
Clinical Pharmacology and Therapeutics|May 12, 2025
Cytochrome P450 2D6 Poor Metabolizers and Risperidone Treatment Failure: A 1-Year Longitudinal StudyMarianna Piras, Setareh Ranjbar, Séverine Crettol, et al.
The Journal of Clinical Psychiatry|December 10, 2015
Importance of early weight changes to predict long-term weight gain during psychotropic drug treatmentFrederik Vandenberghe, Mehdi Gholam-Rezaee, Núria Saigí-Morgui, et al.
Molecular Psychiatry|March 27, 2019
MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patientsDaniella Dwir, Basilio Giangreco, Lijing Xin, et al.
Translational Psychiatry|June 27, 2026
Psychotropic drug-induced weight gain and untargeted metabolomics: machine learning-driven results from a prospective cohort studyMarianna Piras, Gaëlle Magliocco, Setareh Ranjbar, et al.
Pageof 29

Showing results (221-230 of 289) with videos related to

Sort By:
Pageof 29
Basic & Clinical Pharmacology & Toxicology|February 12, 2022
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohortGeorgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Molecular Psychiatry|May 12, 2023
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysisJennifer Sjaarda, Aurélie Delacrétaz, Céline Dubath, et al.
Frontiers in Psychiatry|October 2, 2019
Promotion of Wellbeing for Children of Parents With Mental Illness: A Model Protocol for Research and InterventionCharlotte Reedtz, Karin van Doesum, Giulia Signorini, et al.
Plos One|December 3, 2020
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medicationLuis Alameda, Axel Levier, Mehdi Gholam-Rezaee, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophreniaMichael Berk, Ahmed Munib, Olivia Dean, et al.
Schizophrenia Bulletin|July 15, 2025
Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to AripiprazoleCécile Gras, Marianna Piras, Setareh Ranjbar, et al.
Clinical Pharmacology and Therapeutics|May 12, 2025
Cytochrome P450 2D6 Poor Metabolizers and Risperidone Treatment Failure: A 1-Year Longitudinal StudyMarianna Piras, Setareh Ranjbar, Séverine Crettol, et al.
The Journal of Clinical Psychiatry|December 10, 2015
Importance of early weight changes to predict long-term weight gain during psychotropic drug treatmentFrederik Vandenberghe, Mehdi Gholam-Rezaee, Núria Saigí-Morgui, et al.
Molecular Psychiatry|March 27, 2019
MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patientsDaniella Dwir, Basilio Giangreco, Lijing Xin, et al.
Translational Psychiatry|June 27, 2026
Psychotropic drug-induced weight gain and untargeted metabolomics: machine learning-driven results from a prospective cohort studyMarianna Piras, Gaëlle Magliocco, Setareh Ranjbar, et al.
Pageof 29